Dariohealth (DRIO)Director bought ~$100K

~$100K

Approx. value · 14K sh @ $6.93

43K

Holds after · shares reported

Traded

Jul 23, 2026

Filed

Jul 28, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 10, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 10, 2026, the temporary medical leave of absence of Steven Nelson, President and Chief Commercial Officer of DarioHealth Corp., or the Company, was extended for an indefinite period.”
2. Jul 22, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
3. Jul 23, 2026 · this disclosureInsider · First buy since 2020Director purchased ~$100K of DRIO shares in the open market

What came next

1. Aug 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 20, 2026, the Company and Mr. Nelson entered into a separation agreement (the “Separation Agreement”), pursuant to which Mr. Nelson will cease to serve as the Company’s President and Chief Commercial Officer effective September 1, 2026, and his employment with the Company will terminate effective September 30, 2026 (the “Separation Date”).”
2. Sep 2, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 2, 2026, Lawrence Leisure notified the Board of Directors (the “Board”) of DarioHealth Corp. (the “Company”) of his decision to retire from the Board, effective September 2, 2026, for personal reasons.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Dariohealth

For Dariohealth, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DRIO page.

Other recent filings by Dennis Matheis, Director

• SEC Form 4 at Lucid Diagnostics (LUCD)Aug 22, 2025
• SEC Form 4 at Lucid Diagnostics (LUCD)May 23, 2025
• SEC Form 4 at Lucid Diagnostics (LUCD)May 23, 2025
• SEC Form 4 at Lucid Diagnostics (LUCD)May 23, 2025

The full history of Dennis Matheis, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Dariohealth

• SEC Form 4Aug 27, 2025
• SEC Form 4Nov 14, 2024

Everything OQRO holds on this company is on its DRIO page.